The short version of anti-doping fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-05-18 and is reviewed periodically as new material appears.
AOD9604 is commonly supplied as a white to off-white lyophilized powder. The powder is typically stored at -20 °C or below, protected from light and moisture, because peptides can degrade through oxidation, hydrolysis, or aggregation. If it is reconstituted for laboratory use, an appropriate aqueous buffer or solvent is chosen, and the solution is kept cold and handled to avoid repeated freeze-thaw cycles. These practices support stability but do not imply suitability for human use.
Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography and mass spectrometry. Reversed-phase HPLC separates the peptide from related impurities and can estimate purity by ultraviolet absorbance, while mass spectrometry confirms the molecular mass and detects modifications. Peptide mapping, amino acid analysis, and disulfide mapping may be used when the sequence or disulfide arrangement must be verified. Because AOD9604 contains cysteine residues, oxidation and disulfide isomers are possible quality concerns in synthetic batches.
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Lyophilized form; visual inspection |
| Solubility | Soluble in water and aqueous buffers | Depends on pH, purity, and counterion |
| Typical storage | -20 °C or below, desiccated | Protect from light; avoid repeated freeze-thaw after reconstitution |
| Common analytical method | Reversed-phase HPLC and mass spectrometry | Purity by HPLC; identity and mass by LC-MS or MALDI-TOF |
| Common synonyms | hGH fragment 176–191; AOD-9604 | Names vary in research and product labeling |
Proposed mechanism focuses on lipolysis, the breakdown of stored triglycerides into free fatty acids and glycerol. AOD-9604 is thought to act on adipose tissue without stimulating appetite or affecting blood sugar in the same way as growth hormone. Laboratory studies report increased fat oxidation in some models. The precise receptor interactions and signaling pathways remain incompletely characterized. Researchers have proposed that the peptide may influence fat mobilization through pathways distinct from the full hormone.
Research has examined whether the peptide affects fat mass independently of growth hormone's other actions. Early animal studies suggested reductions in body fat, but species differences and small sample sizes limit interpretation. Human studies have generally been short and have not consistently shown large effects. Some trials measured body composition, lipid profiles, and safety parameters, but the overall picture is one of suggestive yet inconclusive metabolic activity. Findings vary across study populations and protocols.
AOD-9604 has been investigated mainly in the context of body fat and metabolic endpoints. Some early animal and small human studies reported changes in fat mass or lipid markers, but findings were not uniform. Larger, well-controlled trials that would establish efficacy are lacking in the public literature. As a result, claims about weight loss or metabolic benefit remain investigational rather than established. The distinction between a research finding and a proven clinical outcome is central to discussing this peptide.
Regulatory bodies have taken different approaches to AOD-9604. It is not approved as a prescription medicine by major agencies such as the U.S. Food and Drug Administration or the European Medicines Agency. In sport, the World Anti-Doping Agency prohibits peptide hormones, growth factors, and related substances, and AOD-9604 has been treated as a prohibited substance. These regulatory decisions reflect concerns about safety, efficacy, and potential misuse rather than proof of benefit.
Titration curves can be computed within a continuum electrostatics approach with formally exact but more elaborate analytical or Monte Carlo (MC) methods, or inexact but fast approximate methods. MC methods that have been used to compute titration curves are Metropolis MC or Wang–Landau MC. Approximate methods that use a mean-field approach for computing titration curves are the Tanford–Roxby method and hybrids of this method that combine an exact statistical mechanics treatment within clusters of strongly interacting sites with a mean-field treatment of intercluster interactions.
=== Cited texts === Dhillon, Karminder Singh (2009). Malaysian Foreign Policy in the Mahathir Era 1981–2003: Dilemmas of Development. NUS Press. ISBN 978-9971-69-399-2. Milne, R. S.; Mauzy, Diane K. (1999). Malaysian Politics under Mahathir. Routledge. ISBN 0-415-17143-1. Morais, J. Victor (1982). Mahathir: A Profile in Courage. Eastern Universities Press. OCLC 8687329. Sankaran, Ramanathan; Mohd Hamdan Adnan (1988). Malaysia's 1986 General Election: the Urban-Rural Dichotomy. Institute of Southeast Asian Studies. ISBN 981-3035-12-9. Stewart, Ian (2003). The Mahathir Legacy: a Nation Divided, a Region at Risk. Allen & Unwin. ISBN 1-86508-977-X. Wain, Barry (2010). Malaysian Maverick: Mahathir Mohamad in Turbulent Times. Palgrave Macmillan. ISBN 978-0-230-23873-2. James Chin & Joern Dosch. Malaysia Post Mahathir: a decade of change?. Marshall Cavendish. 2016. ISBN 9814677558
19 January – The European Court of Human Rights announces that Ireland launched legal action against the United Kingdom on 17 January over the Northern Ireland Troubles (Legacy and Reconciliation) Act 2023. The UK government gives its backing to the Pet Abduction Bill, a private member's bill that makes it illegal to steal cats and dogs in England and Northern Ireland. 20 January – A speech to the Fabian Society conference by Shadow Foreign Secretary David Lammy is interrupted by pro-Palestinian protestors. 21 January – Scotland's First Minister, Humza Yousaf, tells the BBC's Sunday with Laura Kuenssberg he is willing to work with Sir Keir Starmer if he becomes prime minister after the next general election. 22 January – The House of Lords votes 214–171 in favour of an amendment to the Safety of Rwanda (Asylum and Immigration) Bill that calls for the delay of ratification of the bill until Rwanda improves its asylum procedures. The UK government rejects calls from Welsh MPs to add the Six Nations Championship to the list of guaranteed free-to-air sporting events on British television. 23 January – Following more air strikes against Houthi targets, Sunak tells Parliament the UK would not hesitate to launch further strikes if the rebel group continue to attack shipping targets in the Red Sea, but does not seek confrontation with them.
Sources: en.wikipedia.org
Official website of the Spanish Royal Family Full text of the King's broadcast regarding his abdication Organic Law approving Juan Carlos's abdication, published in the Boletin Oficial del Estado Juan Carlos I abdicates (2 June 2014)
== Preparation == A blood smear is made by placing a drop of blood on one end of a slide, and using a spreader slide to disperse the blood over the slide's length. The aim is to get a region, called a monolayer, where the cells are spaced far enough apart to be counted and differentiated. The monolayer is found in the "feathered edge" created by the spreader slide as it draws the blood forward.
It is formed as result of various attractive forces like hydrogen bonding, disulfide bridges, hydrophobic interactions, hydrophilic interactions, van der Waals force etc. When two or more polypeptide chains (either of identical or of different sequence) cluster to form a protein, quaternary structure of protein is formed. Quaternary structure is an attribute of polymeric (same-sequence chains) or heteromeric (different-sequence chains) proteins like hemoglobin, which consists of two "alpha" and two "beta" polypeptide chains.
Sources: en.wikipedia.org
Chikungunya vaccines are vaccines intended to provide acquired immunity against the chikungunya virus. As of 2025, two vaccines have been licensed in some countries. These are Ixchiq, a live attenuated vaccine from Valneva, and Vimkunya manufactured by Bavarian Nordic which utilises virus-like particle technology. The most commonly reported side effects of Ixchiq include tenderness at the injection site, as well as headache, fatigue, muscle pain, joint pain, fever, and nausea. However the license for Ixchiq has been suspended or restricted in some countries due to the risk of severe side effects, particularly in older people.
== Clinical significance == Leukotrienes, which require the FLAP protein to be synthesized, have an established pathological role in allergic and respiratory diseases. Animal and human genetic evidence suggests they may also have an important role in atherosclerosis, myocardial infarction, and stroke. The structure of FLAP provides a tool for the development of novel therapies for respiratory and cardiovascular diseases and for the design of focused experiments to probe the cell biology of FLAP and its role in leukotriene biosynthesis.
=== Allenstein / Olsztyn Plebiscite Area === The Allied forces had to intervene here in 1919 to release imprisoned Masurians, who had tried to reach the Paris Conference. The president and British commissioner of the Inter-Allied Administrative and Plebiscite Commission for Allenstein was Ernest Rennie; the French commissioner was Couget; the Italian commissioner was Marquis Fracassi, a senator; and the Japanese commissioner was Marumo. The German government, under the Protocol's terms, was allowed to attach a delegate and sent Reichskommissar Wilhelm von Gayl, who had been in the service of the Interior Ministry before he was on the Inner Colonisation Committee. The local police forces were placed under the control of two British officers: Lieutenant-Colonel Bennet and Major David Deevis. Bennet reported that he regarded them as "well-disciplined and reliable". There was also a battalion from the Royal Irish Regiment and an Italian regiment stationed at Lyck (Ełk).
Sources: en.wikipedia.org
Lyophilized AOD9604 is generally kept at -20 °C or colder, desiccated, and protected from light. Reconstituted solutions are usually refrigerated and handled to minimize repeated freeze-thaw cycles. These are general laboratory handling practices, not instructions for human use.
Mass spectrometry, such as LC-MS or MALDI-TOF, confirms the molecular mass and can reveal sequence-related impurities. Reversed-phase HPLC is used for purity, and peptide mapping or amino acid analysis can support sequence identity. No single method establishes every quality attribute.
No. AOD9604 is a short synthetic fragment of the hGH sequence, not the full 191-amino-acid hormone. It lacks the regions that mediate hGH receptor activation and growth-promoting effects. Products labeled as AOD9604 should not be assumed to have the same properties as hGH.
AOD-9604 is a synthetic peptide fragment of human growth hormone. It corresponds to the C-terminal region known as hGH 176-191 and is studied for metabolic effects. It is not an approved therapeutic drug.